Skip to main content
Screener/Healthcare/Biotechnology

LGND — Ligand Pharmaceuticals Incorporated

NASDAQ
$291.69-4.51 (-1.52%)
Mid CapHealthcare
$129.55
$326.63
$286.22
$301.93
EPS (TTM)$7.37
P/E Ratio39.58
Dividend Yield0.15%
Market Cap$5.96B
Volume164K
Prev Close$296.29
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$51.7M-$13.3M$-0.670.0%-25.8%
Q4 '25$59.7M$44.8M$2.12143.6%75.1%
Q3 '25$115.5M$117.3M$5.6878.5%101.6%
Q2 '25$47.6M$4.8M$0.2493.9%10.2%
Q1 '25$45.3M-$42.5M$-2.2189.3%-93.6%
Q4 '24$42.8M-$31.1M$-1.6493.4%-72.6%
Q3 '24$51.8M-$7.2M$-0.3975.9%-13.8%
Q2 '24$41.5M-$51.9M$-2.88136.9%-125.0%
Get Your Daily Market Recap